TotalMarketCap

Kairos Pharma

KAPANYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.546 M

$0.46 -6.74%

Close of 6 Nov 2026

As of 6 Nov 2026, Kairos Pharma (KAPA) has a market capitalization of $1.55M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$5.45M

Loss-making

Shares outstanding

23,697,683

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #488XORTX TherapeuticsXRTX$1.65M
  2. #489OragenicsOGEN$1.55M
  3. #490Kairos PharmaKAPA$1.55M
  4. #491Lakewood-Amedex BiotherapeuticsLABT$1.42M
  5. #492Karyopharm TherapeuticsKPTI$1.40M

What if Kairos Pharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$8,340,823

Per share 18,263,244× higher

Bitcoin $1.53T

$451,307.43

Per share 988,192× higher

Apple $5.02T

$1,481,600

Per share 3,244,143× higher

Or at a round number

$2.00M$5.00M$10.0M$20.0M

Where these numbers come from

Share counts and financials for Kairos Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.